Suppr超能文献

一种新型强脉冲光系统治疗葡萄酒色斑的疗效

Efficacy of a novel intense pulsed light system for the treatment of port wine stains.

作者信息

Adatto Maurice A, Luc-Levy Jean, Mordon Serge

机构信息

Skinpulse Dermatology & Laser Center, Geneva, Switzerland.

出版信息

J Cosmet Laser Ther. 2010 Apr;12(2):54-60. doi: 10.3109/14764171003706158.

Abstract

BACKGROUND AND OBJECTIVES

Port wine stains (PWS) are capillary malformations typically treated with lasers or with intense pulsed light (IPL). This paper summarizes our safety and efficacy findings for a new IPL designed to target the dermal vessels of PWS.

METHODS

The PWS received three to four treatments with a novel IPL containing a vascular-specific handpiece (LuxG, dual wavelength band of 500-670 nm and 870-1400 nm; Palomar Medical Technologies, Inc.). Clinical benefit was assessed qualitatively with a quartile-assessment scale and quantitatively with a skinphotometer.

RESULTS

Three months post-treatment, over 50% of PWS exhibited statistically significant improvements of 51-75% or higher. The pre-treatment PWS mean erythema value of 189.72+/-18.40 (95% Confidence Interval [CI]) was reduced to 147.22+/-16.15 post-treatment, thereby approaching the normal skin erythema value of 117.61 +/- 15.90. The mean percent reduction in vascularity at 3 months was statistically significant at -55.4 (p=0.0000003). Treatments were well-tolerated with minimal to no subject downtime and limited side effects of transient erythema (all subjects) or mild crusting and mild purpura (n=1).

CONCLUSION

These results demonstrate the efficacy and safety of this novel IPL in providing therapeutic benefit to patients suffering from PWS.

摘要

背景与目的

葡萄酒色斑(PWS)是一种毛细血管畸形,通常采用激光或强脉冲光(IPL)进行治疗。本文总结了我们使用一种新型IPL治疗PWS真皮血管的安全性和有效性研究结果。

方法

对PWS患者使用一种新型IPL进行三到四次治疗,该IPL配备了血管特异性手持探头(LuxG,500 - 670 nm和870 - 1400 nm双波段;帕洛玛医疗技术公司)。通过四分位数评估量表进行临床获益的定性评估,并使用皮肤光度计进行定量评估。

结果

治疗三个月后,超过50%的PWS患者显示出51% - 75%或更高的统计学显著改善。治疗前PWS的平均红斑值为189.72±18.40(95%置信区间[CI]),治疗后降至147.22±16.15,接近正常皮肤红斑值117.61±15.90。三个月时血管减少的平均百分比在统计学上显著,为-55.4(p = 0.0000003)。治疗耐受性良好,受试者停机时间最短或无停机时间,副作用有限,表现为短暂红斑(所有受试者)或轻度结痂和轻度紫癜(n = 1)。

结论

这些结果证明了这种新型IPL对PWS患者具有治疗益处的有效性和安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验